Monotherapy with a novel intervenolin derivative, AS ‐1934, is an effective treatment for Helicobacter pylori infection

ConclusionAS‐1934 has potential advantages over current treatment options for H. pylori infection.

Source: Helicobacter - February 1, 2018 Category: Gastroenterology Authors: Tomokazu Ohishi, Tohru Masuda, Hikaru Abe, Chigusa Hayashi, Hayamitsu Adachi, Shun ‐ichi Ohba, Masayuki Igarashi, Takumi Watanabe, Hitomi Mimuro, Eri Amalia, Daniel Ken Inaoka, Kota Mochizuki, Kiyoshi Kita, Masakatsu Shibasaki, Manabu Kawada Tags: ORIGINAL ARTICLE Source Type: research